ESG Report

Overview

The report covers Starpharma's FY24 operations across all group companies and organizes ESG disclosure around Environment, Our People, Products and Patient Health, and Governance. It reports Scope 1 emissions of 15.04 t. CO2-e and Scope 2 emissions of 357.18 t. CO2-e, estimated water consumption of 259 kilolitres (kl), and no notifiable accidents or illnesses. Women represented 33% of directors, while the report highlights a 55% female employee population excluding the Board and a 51% whole-organisation figure. Starpharma states that the Board oversees climate-related matters and that the report was not subject to external audit.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services